Tackling brain tumours, understanding immunotherapy and revealing cancer’s genetics at the end of life – accelerating progress at our Centres
We've announced four new awards to speed up research in our Centres, particularly for cancers where survival is still poor.
We look back on the key topics and trends discussed at the American Association of Cancer Research's recent Annual Meeting in New Orleans
Several new immunotherapy drugs are continuing to show benefits across a range of cancer types, according to data presented at a US conference.
We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells.
We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples.
Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system.
Our scientists may have uncovered the 'guidance system' needed to make cancer immunotherapy more effective.
Scientists have made a groundbreaking discovery in understanding how the genetic complexity of tumours can be recognised and exploited by the immune system.
From immunotherapy to 'targeted' drugs, we report back from a recent conference on lung cancer.